Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

NCT04855435 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Uveal Melanoma, Metastatic
Cutaneous Melanoma

Interventions

DRUG: MBS8(1V270)
DRUG: MBS8(1V270) and pembrolizumab combination

Sponsor

MonTa Biosciences ApS